Study Protocol: Global Research Initiative on the Neurophysiology of Schizophrenia (GRINS) project.

Biomarkers Bipolar disorder Brain dynamics Event-related potential Neurophysiological mechanism Psychiatric disorders Schizophrenia Sleep EEG

Journal

BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559

Informations de publication

Date de publication:
10 Jun 2024
Historique:
received: 25 01 2024
accepted: 31 05 2024
medline: 11 6 2024
pubmed: 11 6 2024
entrez: 10 6 2024
Statut: epublish

Résumé

Objective and quantifiable markers are crucial for developing novel therapeutics for mental disorders by 1) stratifying clinically similar patients with different underlying neurobiological deficits and 2) objectively tracking disease trajectory and treatment response. Schizophrenia is often confounded with other psychiatric disorders, especially bipolar disorder, if based on cross-sectional symptoms. Awake and sleep EEG have shown promise in identifying neurophysiological differences as biomarkers for schizophrenia. However, most previous studies, while useful, were conducted in European and American populations, had small sample sizes, and utilized varying analytic methods, limiting comprehensive analyses or generalizability to diverse human populations. Furthermore, the extent to which wake and sleep neurophysiology metrics correlate with each other and with symptom severity or cognitive impairment remains unresolved. Moreover, how these neurophysiological markers compare across psychiatric conditions is not well characterized. The utility of biomarkers in clinical trials and practice would be significantly advanced by well-powered transdiagnostic studies. The Global Research Initiative on the Neurophysiology of Schizophrenia (GRINS) project aims to address these questions through a large, multi-center cohort study involving East Asian populations. To promote transparency and reproducibility, we describe the protocol for the GRINS project. The research procedure consists of an initial screening interview followed by three subsequent sessions: an introductory interview, an evaluation visit, and an overnight neurophysiological recording session. Data from multiple domains, including demographic and clinical characteristics, behavioral performance (cognitive tasks, motor sequence tasks), and neurophysiological metrics (both awake and sleep electroencephalography), are collected by research groups specialized in each domain. Pilot results from the GRINS project demonstrate the feasibility of this study protocol and highlight the importance of such research, as well as its potential to study a broader range of patients with psychiatric conditions. Through GRINS, we are generating a valuable dataset across multiple domains to identify neurophysiological markers of schizophrenia individually and in combination. By applying this protocol to related mental disorders often confounded with each other, we can gather information that offers insight into the neurophysiological characteristics and underlying mechanisms of these severe conditions, informing objective diagnosis, stratification for clinical research, and ultimately, the development of better-targeted treatment matching in the clinic.

Sections du résumé

BACKGROUND BACKGROUND
Objective and quantifiable markers are crucial for developing novel therapeutics for mental disorders by 1) stratifying clinically similar patients with different underlying neurobiological deficits and 2) objectively tracking disease trajectory and treatment response. Schizophrenia is often confounded with other psychiatric disorders, especially bipolar disorder, if based on cross-sectional symptoms. Awake and sleep EEG have shown promise in identifying neurophysiological differences as biomarkers for schizophrenia. However, most previous studies, while useful, were conducted in European and American populations, had small sample sizes, and utilized varying analytic methods, limiting comprehensive analyses or generalizability to diverse human populations. Furthermore, the extent to which wake and sleep neurophysiology metrics correlate with each other and with symptom severity or cognitive impairment remains unresolved. Moreover, how these neurophysiological markers compare across psychiatric conditions is not well characterized. The utility of biomarkers in clinical trials and practice would be significantly advanced by well-powered transdiagnostic studies. The Global Research Initiative on the Neurophysiology of Schizophrenia (GRINS) project aims to address these questions through a large, multi-center cohort study involving East Asian populations. To promote transparency and reproducibility, we describe the protocol for the GRINS project.
METHODS METHODS
The research procedure consists of an initial screening interview followed by three subsequent sessions: an introductory interview, an evaluation visit, and an overnight neurophysiological recording session. Data from multiple domains, including demographic and clinical characteristics, behavioral performance (cognitive tasks, motor sequence tasks), and neurophysiological metrics (both awake and sleep electroencephalography), are collected by research groups specialized in each domain.
CONCLUSION CONCLUSIONS
Pilot results from the GRINS project demonstrate the feasibility of this study protocol and highlight the importance of such research, as well as its potential to study a broader range of patients with psychiatric conditions. Through GRINS, we are generating a valuable dataset across multiple domains to identify neurophysiological markers of schizophrenia individually and in combination. By applying this protocol to related mental disorders often confounded with each other, we can gather information that offers insight into the neurophysiological characteristics and underlying mechanisms of these severe conditions, informing objective diagnosis, stratification for clinical research, and ultimately, the development of better-targeted treatment matching in the clinic.

Identifiants

pubmed: 38858652
doi: 10.1186/s12888-024-05882-1
pii: 10.1186/s12888-024-05882-1
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

433

Investigateurs

Yifan Sun (Y)
Duxing Li (D)
Zixuan Huang (Z)
Jikang Liu (J)
Guanchen Gai (G)
Kai Zou (K)
Zhe Wang (Z)
Xiaoman Yu (X)
Limin Chen (L)
Xuezheng Gao (X)
Guoqiang Wang (G)
Wei Zhu (W)
Jess Wang (J)
Lei A Wang (LA)
Yining Wang (Y)
Hongliang Zhou (H)
Shen Li (S)

Informations de copyright

© 2024. The Author(s).

Références

Chang WC, Wong CSM, Chen EYH, Lam LCW, Chan WC, Ng RMK, Hung SF, Cheung EFC, Sham PC, Chiu HFK, et al. Lifetime prevalence and correlates of schizophrenia-spectrum, affective, and other non-affective psychotic disorders in the Chinese adult population. Schizophr Bull. 2017;43(6):1280–90.
pubmed: 28586480 pmcid: 5737409 doi: 10.1093/schbul/sbx056
Knapp M, Mangalore R, Simon J. The global costs of schizophrenia. Schizophr Bull. 2004;30(2):279–93.
pubmed: 15279046 doi: 10.1093/oxfordjournals.schbul.a007078
Miyamoto S, Duncan GE, Marx CE, Lieberman JA. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry. 2005;10(1):79–104.
pubmed: 15289815 doi: 10.1038/sj.mp.4001556
Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet. 2016;388(10039):86–97.
McGorry PD, Hartmann JA, Spooner R, Nelson B. Beyond the “at risk mental state” concept: transitioning to transdiagnostic psychiatry. World Psychiatry. 2018;17(2):133–42.
pubmed: 29856558 pmcid: 5980504 doi: 10.1002/wps.20514
Cassel JC, de Vasconcelos AP. The cognitive thalamus: a bridal chamber not to forget. Neurosci Biobehav Rev. 2015;54:1–2.
pubmed: 25616184 doi: 10.1016/j.neubiorev.2015.01.017
Saalmann YB, Kastner S. The cognitive thalamus. Front Syst Neurosci. 2015;9:39.
pubmed: 25852498 pmcid: 4362213 doi: 10.3389/fnsys.2015.00039
Wolff M, Vann SD. The Cognitive Thalamus as a Gateway to Mental Representations. J Neurosci. 2019;39(1):3–14.
pubmed: 30389839 pmcid: 6325267 doi: 10.1523/JNEUROSCI.0479-18.2018
Deicken RF, Eliaz Y, Chosiad L, Feiwell R, Rogers L. Magnetic resonance imaging of the thalamus in male patients with schizophrenia. Schizophr Res. 2002;58(2–3):135–44.
pubmed: 12409153 doi: 10.1016/S0920-9964(01)00330-9
Csernansky JG, Schindler MK, Splinter NR, Wang L, Gado M, Selemon LD, Rastogi-Cruz D, Posener JA, Thompson PA, Miller MI. Abnormalities of thalamic volume and shape in schizophrenia. Am J Psychiatry. 2004;161(5):896–902.
pubmed: 15121656 doi: 10.1176/appi.ajp.161.5.896
Ferri J, Ford JM, Roach BJ, Turner JA, van Erp TG, Voyvodic J, Preda A, Belger A, Bustillo J, O’Leary D, et al. Resting-state thalamic dysconnectivity in schizophrenia and relationships with symptoms. Psychol Med. 2018;48(15):2492–9.
pubmed: 29444726 doi: 10.1017/S003329171800003X
Avram M, Brandl F, Bauml J, Sorg C. Cortico-thalamic hypo- and hyperconnectivity extend consistently to basal ganglia in schizophrenia. Neuropsychopharmacology. 2018;43(11):2239–48.
pubmed: 29899404 pmcid: 6135808 doi: 10.1038/s41386-018-0059-z
Bernard JA, Orr JM, Mittal VA. Cerebello-thalamo-cortical networks predict positive symptom progression in individuals at ultra-high risk for psychosis. Neuroimage Clin. 2017;14:622–8.
pubmed: 28348953 pmcid: 5357699 doi: 10.1016/j.nicl.2017.03.001
Barch DM. Cerebellar-thalamic connectivity in schizophrenia. Schizophr Bull. 2014;40(6):1200–3.
pubmed: 24894882 pmcid: 4193726 doi: 10.1093/schbul/sbu076
Cao H, Chen OY, Chung Y, Forsyth JK, McEwen SC, Gee DG, Bearden CE, Addington J, Goodyear B, Cadenhead KS, et al. Cerebello-thalamo-cortical hyperconnectivity as a state-independent functional neural signature for psychosis prediction and characterization. Nat Commun. 2018;9(1):3836.
pubmed: 30242220 pmcid: 6155100 doi: 10.1038/s41467-018-06350-7
Anticevic A, Haut K, Murray JD, Repovs G, Yang GJ, Diehl C, McEwen SC, Bearden CE, Addington J, Goodyear B, et al. Association of thalamic dysconnectivity and conversion to psychosis in youth and young adults at elevated clinical risk. JAMA Psychiatry. 2015;72(9):882–91.
pubmed: 26267151 pmcid: 4892891 doi: 10.1001/jamapsychiatry.2015.0566
Baran B, Karahanoglu FI, Mylonas D, Demanuele C, Vangel M, Stickgold R, Anticevic A, Manoach DS. Increased thalamocortical connectivity in schizophrenia correlates with sleep spindle deficits: evidence for a common pathophysiology. Biol Psychiatry Cogn Neurosci Neuroimaging. 2019;4(8):706–14.
pubmed: 31262708 pmcid: 6688951
Miller BJ, McCall WV. Meta-analysis of insomnia, suicide, and psychopathology in schizophrenia. Curr Opin Psychiatry. 2023;36(3):156–65.
pubmed: 36762664 doi: 10.1097/YCO.0000000000000856
Ferrarelli F. Sleep disturbances in schizophrenia and psychosis. Schizophr Res. 2020;221:1–3.
pubmed: 32471787 pmcid: 7316597 doi: 10.1016/j.schres.2020.05.022
Carruthers SP, Brunetti G, Rossell SL. Sleep disturbances and cognitive impairment in schizophrenia spectrum disorders: a systematic review and narrative synthesis. Sleep Med. 2021;84:8–19.
pubmed: 34090012 doi: 10.1016/j.sleep.2021.05.011
Mushtaq M, Marshall L, Bazhenov M, Molle M, Martinetz T. Differential thalamocortical interactions in slow and fast spindle generation: a computational model. PLoS One. 2022;17(12):e0277772.
pubmed: 36508417 pmcid: 9744318 doi: 10.1371/journal.pone.0277772
Neske GT. The Slow Oscillation in Cortical and Thalamic Networks: Mechanisms and Functions. Front Neural Circuits. 2015;9:88.
pubmed: 26834569
Schreiner T, Kaufmann E, Noachtar S, Mehrkens JH, Staudigl T. The human thalamus orchestrates neocortical oscillations during NREM sleep. Nat Commun. 2022;13(1):5231.
pubmed: 36064855 pmcid: 9445182 doi: 10.1038/s41467-022-32840-w
Walker MP, Stickgold R. Sleep-dependent learning and memory consolidation. Neuron. 2004;44(1):121–33.
pubmed: 15450165 doi: 10.1016/j.neuron.2004.08.031
Ambrosius U, Lietzenmaier S, Wehrle R, Wichniak A, Kalus S, Winkelmann J, Bettecken T, Holsboer F, Yassouridis A, Friess E. Heritability of sleep electroencephalogram. Biol Psychiatry. 2008;64(4):344–8.
pubmed: 18405882 doi: 10.1016/j.biopsych.2008.03.002
Purcell SM, Manoach DS, Demanuele C, Cade BE, Mariani S, Cox R, Panagiotaropoulou G, Saxena R, Pan JQ, Smoller JW, et al. Characterizing sleep spindles in 11,630 individuals from the National Sleep Research Resource. Nat Commun. 2017;8:15930.
pubmed: 28649997 pmcid: 5490197 doi: 10.1038/ncomms15930
Geiger A, Huber R, Kurth S, Ringli M, Jenni OG, Achermann P. The sleep EEG as a marker of intellectual ability in school age children. Sleep. 2011;34(2):181–9.
pubmed: 21286251 pmcid: 3022938 doi: 10.1093/sleep/34.2.181
Castelnovo A, Zago M, Casetta C, Zangani C, Donati F, Canevini M, Riedner BA, Tononi G, Ferrarelli F, Sarasso S, et al. Slow wave oscillations in schizophrenia first-degree relatives: a confirmatory analysis and feasibility study on slow wave traveling. Schizophr Res. 2020;221:37–43.
pubmed: 32220503 doi: 10.1016/j.schres.2020.03.025
Ferrarelli F. Sleep abnormalities in schizophrenia: state of the art and next steps. Am J Psychiatry. 2021;178(10):903–13.
pubmed: 33726524 pmcid: 8446088 doi: 10.1176/appi.ajp.2020.20070968
Lai M, Hegde R, Kelly S, Bannai D, Lizano P, Stickgold R, Manoach DS, Keshavan M. Investigating sleep spindle density and schizophrenia: a meta-analysis. Psychiatry Res. 2022;307:114265.
pubmed: 34922240 doi: 10.1016/j.psychres.2021.114265
Sun JB, Deng H, Wang SY, Cui YP, Yang XJ, Wang CY, Chen YH, Yang Q, Wang HN, Qin W. The feature of sleep spindle deficits in patients with schizophrenia with and without auditory verbal hallucinations. Biol Psychiatry Cogn Neurosci Neuroimaging. 2023;8(3):331–42.
pubmed: 34380082
Onitsuka T, Tsuchimoto R, Oribe N, Spencer KM, Hirano Y. Neuronal imbalance of excitation and inhibition in schizophrenia: a scoping review of gamma-band ASSR findings. Psychiatry Clin Neurosci. 2022;76(12):610–9.
pubmed: 36069299 doi: 10.1111/pcn.13472
Coffman BA, Ren X, Longenecker J, Torrence N, Fishel V, Seebold D, Wang Y, Curtis M, Salisbury DF. Aberrant attentional modulation of the auditory steady state response (ASSR) is related to auditory hallucination severity in the first-episode schizophrenia-spectrum. J Psychiatr Res. 2022;151:188–96.
pubmed: 35490500 pmcid: 9703618 doi: 10.1016/j.jpsychires.2022.03.059
Freedman R, Olsen-Dufour AM, Olincy A. Consortium on the Genetics of S: P50 inhibitory sensory gating in schizophrenia: analysis of recent studies. Schizophr Res. 2020;218:93–8.
pubmed: 32061454 pmcid: 7299819 doi: 10.1016/j.schres.2020.02.003
Atagun MI, Drukker M, Hall MH, Altun IK, Tatli SZ, Guloksuz S, van Os J, van Amelsvoort T. Meta-analysis of auditory P50 sensory gating in schizophrenia and bipolar disorder. Psychiatry Res Neuroimaging. 2020;300:111078.
pubmed: 32361172 doi: 10.1016/j.pscychresns.2020.111078
Takahashi Y, Fujii S, Osakabe Y, Hoshino H, Konno R, Kakamu T, Fukushima T, Matsumoto T, Yoshida K, Aoki S, et al. Impaired mismatch negativity reflects the inability to perceive beat interval in patients with schizophrenia. Schizophr Res. 2023;254:40–1.
pubmed: 36796272 doi: 10.1016/j.schres.2023.02.014
Hua JPY, Roach BJ, Ford JM, Mathalon DH. Mismatch negativity and theta oscillations evoked by auditory deviance in early schizophrenia. Biol Psychiatry Cogn Neurosci Neuroimaging. 2023;8(12):1186–96.
Zangani C, Casetta C, Saunders AS, Donati F, Maggioni E, D’Agostino A. Sleep abnormalities across different clinical stages of bipolar disorder: a review of EEG studies. Neurosci Biobehav Rev. 2020;118:247–57.
pubmed: 32738263 doi: 10.1016/j.neubiorev.2020.07.031
Xiao W, Manyi G, Khaleghi A. Deficits in auditory and visual steady-state responses in adolescents with bipolar disorder. J Psychiatr Res. 2022;151:368–76.
pubmed: 35551068 doi: 10.1016/j.jpsychires.2022.04.041
Kim S, Jeon H, Jang KI, Kim YW, Im CH, Lee SH. Mismatch negativity and cortical thickness in patients with schizophrenia and bipolar disorder. Schizophr Bull. 2019;45(2):425–35.
pubmed: 29684224 doi: 10.1093/schbul/sby041
Bovy L, Weber FD, Tendolkar I, Fernandez G, Czisch M, Steiger A, Zeising M, Dresler M. Non-REM sleep in major depressive disorder. Neuroimage Clin. 2022;36:103275.
pubmed: 36451376 pmcid: 9723407 doi: 10.1016/j.nicl.2022.103275
Ritter PS, Schwabedal J, Brandt M, Schrempf W, Brezan F, Krupka A, Sauer C, Pfennig A, Bauer M, Soltmann B, et al. Sleep spindles in bipolar disorder - a comparison to healthy control subjects. Acta Psychiatr Scand. 2018;138(2):163–72.
pubmed: 29974456 doi: 10.1111/acps.12924
Grande I, Berk M, Birmaher B, Vieta E. Bipolar disorder. Lancet. 2016;387(10027):1561–72.
pubmed: 26388529 doi: 10.1016/S0140-6736(15)00241-X
Cross-Disorder Group of the Psychiatric Genomics C, Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, Mowry BJ, Thapar A, Goddard ME et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013, 45(9):984-994.
Palmer DS, Howrigan DP, Chapman SB, Adolfsson R, Bass N, Blackwood D, Boks MPM, Chen CY, Churchhouse C, Corvin AP, et al. Exome sequencing in bipolar disorder identifies AKAP11 as a risk gene shared with schizophrenia. Nat Genet. 2022;54(5):541–7.
pubmed: 35410376 pmcid: 9117467 doi: 10.1038/s41588-022-01034-x
Cumming D, Kozhemiako N, Thurm AE, Farmer CA, Purcell SW, Buckley AW. Spindle chirp and other sleep oscillatory features in young children with autism. bioRxiv. 2023. https://doi.org/10.1101/2023.06.15.545095 .
Chung F, Subramanyam R, Liao P, Sasaki E, Shapiro C, Sun Y. High STOP-Bang score indicates a high probability of obstructive sleep apnoea. Br J Anaesth. 2012;108(5):768–75.
pubmed: 22401881 pmcid: 3325050 doi: 10.1093/bja/aes022
Kozhemiako N, Wang J, Jiang C, Wang LA, Gai G, Zou K, Wang Z, Yu X, Zhou L, Li S, et al. Non-rapid eye movement sleep and wake neurophysiology in schizophrenia. Elife. 2022;11:e76211.
Li X, Deng W, Xue R, Wang Q, Ren H, Wei W, Zhang Y, Li M, Zhao L, Du X, et al. Auditory event-related potentials, neurocognition, and global functioning in drug naive first-episode schizophrenia and bipolar disorder. Psychol Med. 2023;53(3):785–94.
pubmed: 34474699 doi: 10.1017/S0033291721002130
Hall MH, Schulze K, Rijsdijk F, Picchioni M, Ettinger U, Bramon E, Freedman R, Murray RM, Sham P. Heritability and reliability of P300, P50 and duration mismatch negativity. Behav Genet. 2006;36(6):845–57.
pubmed: 16826459 doi: 10.1007/s10519-006-9091-6
Hall MH, Schulze K, Rijsdijk F, Kalidindi S, McDonald C, Bramon E, Murray RM, Sham P. Are auditory P300 and duration MMN heritable and putative endophenotypes of psychotic bipolar disorder? A Maudsley Bipolar Twin and Family Study. Psychol Med. 2009;39(8):1277–87.
pubmed: 19250581 doi: 10.1017/S0033291709005261
Murphy M, Wang J, Jiang C, Wang LA, Kozhemiako N, Wang Y, Consortium G, Pan JQ, Purcell SM. A potential source of bias in group-level EEG microstate analysis. Brain Topogr. 2024;37(2):232–42.
Manoach DS, Stickgold R. Abnormal sleep spindles, memory consolidation, and schizophrenia. Annu Rev Clin Psychol. 2019;15:451–79.
pubmed: 30786245 pmcid: 7307009 doi: 10.1146/annurev-clinpsy-050718-095754
Manoach DS, Cain MS, Vangel MG, Khurana A, Goff DC, Stickgold R. A failure of sleep-dependent procedural learning in chronic, medicated schizophrenia. Biol Psychiatry. 2004;56(12):951–6.
pubmed: 15601605 doi: 10.1016/j.biopsych.2004.09.012
Wamsley EJ, Tucker MA, Shinn AK, Ono KE, McKinley SK, Ely AV, Goff DC, Stickgold R, Manoach DS. Reduced sleep spindles and spindle coherence in schizophrenia: mechanisms of impaired memory consolidation? Biol Psychiatry. 2012;71(2):154–61.
pubmed: 21967958 doi: 10.1016/j.biopsych.2011.08.008
McCutcheon RA, Krystal JH, Howes OD. Dopamine and glutamate in schizophrenia: biology, symptoms and treatment. World Psychiatry. 2020;19(1):15–33.
pubmed: 31922684 pmcid: 6953551 doi: 10.1002/wps.20693
Wang S, Li Z, Wang X, Li J, Wang X, Chen J, Li Y, Wang C, Qin L. Cortical and thalamic modulation of auditory gating in the posterior parietal cortex of awake mice. Cereb Cortex. 2023;33(11):6742–60.
Kim M, Kim T, Ha M, Oh H, Moon SY, Kwon JS. Large-scale thalamocortical triple network dysconnectivities in patients with first-episode psychosis and individuals at risk for psychosis. Schizophr Bull. 2023;49(2):375–84.
pubmed: 36453986 doi: 10.1093/schbul/sbac174
Angulo Salavarria MM, Dell’Amico C, D’Agostino A, Conti L, Onorati M. Cortico-thalamic development and disease: From cells, to circuits, to schizophrenia. Front Neuroanat. 2023;17:1130797.
pubmed: 36935652 pmcid: 10019505 doi: 10.3389/fnana.2023.1130797
Boutin A, Pinsard B, Bore A, Carrier J, Fogel SM, Doyon J. Transient synchronization of hippocampo-striato-thalamo-cortical networks during sleep spindle oscillations induces motor memory consolidation. Neuroimage. 2018;169:419–30.
pubmed: 29277652 doi: 10.1016/j.neuroimage.2017.12.066
Mayeli A, Janssen SA, Sharma K, Ferrarelli F. Examining first night effect on sleep parameters with hd-EEG in healthy individuals. Brain Sci. 2022;12(2):233.
Mylonas D, Baran B, Demanuele C, Cox R, Vuper TC, Seicol BJ, Fowler RA, Correll D, Parr E, Callahan CE, et al. The effects of eszopiclone on sleep spindles and memory consolidation in schizophrenia: a randomized clinical trial. Neuropsychopharmacology. 2020;45(13):2189–97.
pubmed: 32919407 pmcid: 7785021 doi: 10.1038/s41386-020-00833-2
Mylonas D, Tocci C, Coon WG, Baran B, Kohnke EJ, Zhu L, Vangel MG, Stickgold R, Manoach DS. Naps reliably estimate nocturnal sleep spindle density in health and schizophrenia. J Sleep Res. 2020;29(5):e12968.
pubmed: 31860157 doi: 10.1111/jsr.12968

Auteurs

Jun Wang (J)

The Affiliated Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, China.

Chenguang Jiang (C)

The Affiliated Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, China.

Zhenglin Guo (Z)

Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, United States.

Sinéad Chapman (S)

Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, United States.

Nataliia Kozhemiako (N)

Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, United States.

Dimitrios Mylonas (D)

Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, United States.

Yi Su (Y)

Psychiatry Research Center, Beijing Huilongguan Hospital, Peking University Huilongguan Clinical Medical School, Beijing, China.

Lin Zhou (L)

Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, United States.

Lu Shen (L)

Bio-X Institutes, Shanghai Jiao Tong University, Shanghai, China.

Shengying Qin (S)

Bio-X Institutes, Shanghai Jiao Tong University, Shanghai, China.

Michael Murphy (M)

Department of Psychiatry, McLean Hospital, Harvard Medical School, Belmont, United States.

Shuping Tan (S)

Psychiatry Research Center, Beijing Huilongguan Hospital, Peking University Huilongguan Clinical Medical School, Beijing, China.

Dara S Manoach (DS)

Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, United States.

Robert Stickgold (R)

Beth Israel Deaconess Medical Center, Boston, United States.
Department of Psychiatry, Harvard Medical School, Boston, United States.

Hailiang Huang (H)

Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, United States.
Analytic and Translational Genetics Unit, Massachusetts General Hospital, Harvard Medical School, Boston, United States.

Zhenhe Zhou (Z)

The Affiliated Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, China.

Shaun M Purcell (SM)

Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, United States.
Department of Psychiatry, Harvard Medical School, Boston, United States.

Meihua Hall (M)

Department of Psychiatry, McLean Hospital, Harvard Medical School, Belmont, United States.

Steven E Hyman (SE)

Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, United States.

Jen Q Pan (JQ)

Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, United States. jpan@broadinstitute.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH